Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2005

01-12-2005 | Other Research Articles

Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs

Authors: Lauretta E. Grau, Ricky N. Bluthenthal, Patricia Marshall, Merrill Singer, Robert Heimer

Published in: AIDS and Behavior | Issue 4/2005

Login to get access

Abstract

Most research on the benefits of syringe exchange programs (SEPs) has focused on assessing program effectiveness and identifying risk profiles of SEP customers. To our knowledge, no empirical studies have considered the psychosocial characteristics of IDUs who do and do not use SEPs. To determine whether IDUs who do and do not use SEPs differ along demographic, psychosocial, and HIV risk characteristics and behaviors, we analyzed data from a three-city (Chicago, IL; Hartford, CT; Oakland, CA) observational study of how HIV prevention messages and supplies diffuse from SEPs. The study sample consisted of 350 participants with no reported history of HIV, hepatitis B or C virus infection. Self-efficacy was the only psychosocial factor to differentiate SEP customers from all non-customers groups; injecting others and pre-injection cleaning of the injection site differentiated some non-customers from customers. Implications for future interventions are discussed.
Literature
Abraham, C. S., Sheeran, P., Abrams, D., and Spears, R. (1994). Exploring teenagers’ adaptive and maladaptive thinking in relation to the threat of HIV infection. Psychology and Health, 9, 253–272.CrossRef
Academy of Educational Development. (2000). A comprehensive approach: Preventing blood-borne infections among injection drug users. New York, New York: Centers for Disease Control and Prevention.
Bourgois, P., and Bruneau, J. (2000). Needle exchange, HIV infection, and the politics of science: Confronting Canada's cocaine injection epidemic with participant observation. Medical Anthrolopology, 18, 325–350.
Broadhead, R. S., Heckathorn, D. D., Grund, J.-P. C., Stern, L. S., and Anthony, D. L. (1995). Drug users versus outreach workers in combatting AIDS: Preliminary evidence of a peer-driven intervention. Journal of Drug Issues, 23(3), 531–564.
Bruneau, J., Lamothe, F., Franco, E., Lachance, N., Désy, M., Soto, J., et al. (1997). High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results from a cohort study. American Journal of Epidemiology, 146, 994–1002.PubMed
Celentano, D. D., Cohn, S., Davis, R. O., and Vlahov, D. (2002). Self-efficacy estimates for drug use practices predict risk reduction among injection drug users. Journal of Urban Health, 79(2), 245–256.PubMed
Covert, M., Tangney, J., Maddux, J., and Heleno, N. (2003). Shame-proneness, guilt-proneness, and interpersonal problem solving: A social cognitive analysis. Journal of Social and Clinical Psychology, 22(1), 1–12.CrossRef
Dreman, S., Orr, E., and Aldor, R. (1989). Competence or dissonance? Divorcing mothers’ perceptions of sense of competence and time perspective. Journal of Marriage and the Family, 51(2), 405–415.CrossRef
Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., and Alexander, E. R. (1999). Syringe exchange and risk of infection with hepatitis B and C viruses. American Journal Epidemiology, 149, 203–213.
Hawkins, W. E., Latkin, C. A., Mandel, W., and Oziemkowska, M. (1999). Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Education and Prevention, 11(2), 122–131.PubMed
Heimer, R., Bluthenthal, R., Singer, M., and Khoshnood, K. (1996). Structural impediments to operational syringe exchange programs. AIDS and Public Policy, 11, 169–184.
Heimer, R., Clair, S., Grau, L., Bluthenthal, R., Marshall, P., and Singer, M. (2002). Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction, 97, 1277–1287.PubMedCrossRef
Henman, A., Paone, D., Des Jarlais, D., Kochems, L., and Friedman, S. (1998). From ideology to logistics: The organizational aspects of syringe exchange in a period of institutional consolidation. Substance Use and Misuse, 33, 1213–1230.PubMedCrossRef
Hofman, N., Strenski, T., Marshall, P., and Heimer, R. (2003). Maintaining respectability and responsibility: Gendered labor patterns among women injection drug users. Health Care for Women International, 24, 794–807.PubMedCrossRef
Kanfer, R., and Zeiss, A. (1983). Depression, interpersonal standard setting, and judgments of self-efficacy. Journal of Abnormal Psychology, 92, 319–329.PubMedCrossRef
Kang, S. -Y., Deren, S., Andia, J., Colon, H., and Robles, R. (2004). Effects of changes in perceived self-efficacy on HIV risk behaviors over time. Addictive Behaviors, 29(3), 567–574.PubMedCrossRef
Koester, S. (1994). Copping, running, and paraphernalia laws: Contextual variables and needle risk behavior among injection drug users in Denver. Human Organization, 53, 287–295.
Kral, A. H., and Bluthenthal, R. N. (1997). HIV risk behaviors among injection drug users (IDUs) who are indirect syringe exchangers in Oakland and Richmond, California, 1996. Paper presented at the American Public Health Association 125th Annual Meeting, Indianapolis, IN.
Kral, A. H., Bluthenthal, R. N., Booth, R. E., and Watters, J. K. (1998). HIV seroprevalence among street-recruited injecting drug and crack cocaine users in 16 U.S. Municipalities. American Journal of Public Health, 88, 108–113.PubMed
Latkin, C. A. (1996). The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: The safe study. American Journal of Community Psychology, 24(3), 341–364.PubMedCrossRef
Latkin, C. A. (1998). Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Reports, 113(Suppl 1), 151–159.PubMed
Longshore, D., Stein, J., and Anglin, M. (1996). Ethnic differences in the psychosocial antecedents of needle/syringe disinfection. Drug and Alcohol Dependence, 42(3), 183–196.PubMedCrossRef
Longshore, D., Stein, J., and Anglin, M. (1997). Psychosocial antecedents of needle/syringe disinfection by drug users: A theory-based prospective analysis. AIDS Education and Prevention, 9(5), 442–459.PubMed
Longshore, D., Stein, J., and Conner, B. (2004). Psychosocial antecedents of injection risk reduction: A multivariate analysis. AIDS Education and Prevention, 16(4), 353–366.PubMedCrossRef
Lurie, P., Reingold, A. L., Bowser, B., Chen, D., Foley, J., and Guydish, J. (1993). The public health impact of needle exchange programs in the United States and abroad. San Francisco, CA: University of California and the Centers for Disease Control and Prevention.
Moss, H., Kirisci, L., and Mezzich, A. (1994). Psychiatric comorbidity and self-efficacy to resist heavy drinking in alcoholic and nonalcoholic adolescents. American Journal on Addictions, 3(3), 204–212.CrossRef
National Institute on Drug Abuse. (1991). Risk behavior assessment. Rockville, MD: NIDA.
National Institutes of Health. (1997). Consensus development statement: Interventions to prevent HIV risk behaviors. Paper presented at the Consensus Development Conference #104, Bethesda, MD.
Normand, J., Vlahov, D., and Moses, L. E. (Eds.). (1995). Preventing HIV transmission: The role of sterile needles and bleach. Washington, DC: National Academy Press.
Rhodes, T., Mikhailova, L., Sarang, A., Lowdes, C., Rylkov, A., Khutorskoy, M., et al. (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science and Medicine, 57(1), 39–54.PubMedCrossRef
Rogers, R. W. (1975). A protection motivation theory of fear appeals and attitude change. Journal of Psychology, 91, 93–114.
Saltzman, K., and Holohan, C. (2002). Social support, self-efficacy, and depressive symptoms: An integrative model. Journal of Social and Clinical Psychology, 21(3), 309–322.CrossRef
Springer, K., Sterk, C., TS, J., and Friedman, L. (1999). Syringe disposal options for injection drug users: A community-based perspective. Substance Use and Misuse, 34(13), 1917–1934.PubMed
Strenski, T., Marshall, P., Gacki, J., and Sanchez, C. (2000). The emergent impact of syringe exchange programs on shooting galleries and injection behaviors in three ethnically diverse Chicago neighborhoods. Medical Anthrolopolgy, 18, 415–438.CrossRef
Valente, T. W., Foreman, R. K., Junge, B., and Vlahov, D. (2001). Needle-exchange participation, effectiveness, and policy: Syringe relay, gender, and the paradox of public health. Journal of Urban Health, 78(2), 340–349.PubMed
Van der Velde, F. W., and Van der Pligt, J. (1991). AIDS-related health behavior: Coping, protection motivation, and previous behavior. Journal of Behavioral Medicine, 14, 429–451.PubMedCrossRef
Wiebel, W. W., Jiminez, A., Johnson, W., Ouellet, L., Jovanovic, B., Lampinen, T., Murray, J., O'Brien, M. U. (1996). Risk behavior and HIV seroincidence among out-of-treatment injection drug users: A four-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12(3), 282–289.PubMed
Metadata
Title
Psychosocial and Behavioral Differences Among Drug Injectors who Use and do not Use Syringe Exchange Programs
Authors
Lauretta E. Grau
Ricky N. Bluthenthal
Patricia Marshall
Merrill Singer
Robert Heimer
Publication date
01-12-2005
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2005
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-005-9020-3

Other articles of this Issue 4/2005

AIDS and Behavior 4/2005 Go to the issue

Barrier Methods of Prevention

Condom Attitudes and Behaviors Among Injection Drug Users Participating in California Syringe Exchange Programs

Barrier Methods of Prevention

Introducing Diaphragms into the Mix: What Happens to Male Condom Use Patterns?

Original Article

Psychosocial, Behavioral, and Cultural Predictors of Sexual Risk for HIV Infection Among Latino Men Who Have Sex with Men

Commentary

Critical Issues and Further Questions About Respondent-Driven Sampling: Comment on Ramirez-Valles, et al. (2005)

Other Research Articles

Traditional Healers for HIV/AIDS Prevention and Family Planning, Kiboga District, Uganda: Evaluation of a Program to Improve Practices

Featured Methodological Article

From Networks to Populations: The Development and Application of Respondent-Driven Sampling Among IDUs and Latino Gay Men
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits